Key result
John Baird Glen discovered and developed the intravenous anesthetic propofol, which revolutionized anesthetic practice and earned him the 2018 Lasker~DeBakey Clinical Medical Research Award.
The 2018 Lasker~DeBakey Clinical Medical Research Award recognizes John Baird Glen for the discovery and clinical development of the intravenous anesthetic propofol.
Award recognizes John Baird Glen for the discovery of propofolThe Lasker~DeBakey Award for Clinical Medical Research commends individuals whose achievements have profoundly advanced medicine.In 2018, the Albert and Mary Lasker Foundation honors John (Iain) Baird Glen, BVMS, PhD, for his contributions to the practice of anesthesia.Glen (Figure 1) spearheaded the discovery and clinical development of the i.v.anesthetic propofol, which has been identified among anesthesiologists as the most transformative drug in their field (1), as well as the development of a breakthrough infusion system that helped standardize anesthetic delivery.Together, propofol and its infusion system have remodeled expectations for the precision, safety, and tolerability of anesthesia.
No takes yet. Share an insight, caveat, or question.
Elyse Dankoski (2018) conducted an editorial in Anesthesia. Propofol was evaluated. John Baird Glen discovered and developed the intravenous anesthetic propofol, which revolutionized anesthetic practice and earned him the 2018 Lasker~DeBakey Clinical Medical Research Award.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: